A call for nominations for experts to serve on a Strategic Advisory Group of Experts (SAGE) on Immunization Working Group on COVID-19 Vaccines and Vaccination has been posted on the SAGE website: https://www.who.int/immunization/policy/sage/en/
This SAGE working group will be set up with the aim of establishing an independent process through SAGE to advise WHO and its Member States on the use of initially pre-licensed vaccines, followed by updates as additional information on product use becomes available. The timeliness of setting up this group will ensure a coordinated approach with the vaccine Research and Development (R&D) community, in order to accelerate timelines and maximize global efforts to make evidence-informed policy decisions for the best use of a vaccine against COVID-19. The ultimate goal of a vaccine against COVID-19 is to rapidly contain the pandemic, save lives, protect health care systems, and restore global economies.
The SAGE Working Group is established with a program of work to:
(1) Provide continuous review of the available evidence on the progress of candidate vaccines against COVID-19, and provide regular updates to SAGE;
(2) Provide guidance for the development of prediction models to determine the optimal age groups and target populations for vaccine introduction and guide vaccine introduction for optimal impact, and contribute to updates of target product profiles of vaccines for outbreak and for endemic use;
(3) Prepare policy advice to SAGE on the accelerated use of vaccines (pre-licensure and post-licensure) to mitigate the public health impact of COVID-19, to possibly curtail the ongoing pandemic, as well as to prevent or reduce the risk of spread of disease in the future. This will include recommendations for early allocation of vaccines when vaccine supply is still limited;
(4) Provide guidance to ensure equitable access to vaccination, and guidance on the safety of vaccines when safety data from wider population use become available, in close collaboration with Global Advisory Committee on Vaccine Safety (GACVS).
The Malaria Endgame
Panelists: Gordon Awandare | Lemu Golassa |Lilian M Ang'ang'o | Fitsum G Tadesse
Covering the current state of the field, and future directions and challenges in the fight to eliminate malaria from endemic countries, this ePanel will highlight various aspects of disease prevention, treatment and control, including:
To register please visit: https://virtual.keystonesymposia.org/ks/live/418/page/2223
Read moreCochrane has opened a free access registry of scientific studies in combating COVID-19 in an attempt to provide the world with quick analyses and understanding of evidence emerging from the war against the virus. These resources are important to us, our researchers and clinical carers. Here are some of the helpful links:
https://www.cochrane.org/news/cochrane-launches-new-study-register-support-rapid-evidence-synthesis-global-challenge-combat
https://covid-19.cochrane.org/
https://community.cochrane.org/about-covid-19-study-register
https://community.cochrane.org/search-help-covid-19-study-register
Read moreOnly one day to go until the first livestream of the COVID-19 Online Educational Program. Register for free today and do not miss your chance to hear from the experts at the frontline of this pandemic.
If you have already registered, details on how to join the livestream will be sent to you approximately 24 hours before the scheduled start time.
WEBCAST SCHEDULE
Tuesday, 7 April
20:00 CEST / 14:00 EDT / 11:00 PDT*
Wednesday, 8 April
20:00 EDT / 17:00 PDT*
*Instructions on how to connect will be shared with registrants approx. 24 hours prior to the live stream.
The duration of each livestream will be 90 minutes.
Registration is free for all participants: https://virology.eventsair.com/covid-19/registration/Site/Register
Read more